Medicine

News

Hiroshima University-MSC trial-post-stroke therapy-press conference
01 Dec 2022
Therapeutically superior mesenchymal stem cells derived from the cranial bone offer hope in reversing paralysis and language impairment in moderate to severe cases of stroke.
25 Nov 2022
Asia Research News monitors the latest research news in Asia. Some highlights that caught our attention this week are a new planet that orbits a dying star, a map of all the airborne microbes, and the potential to protect our organs by hibernating during surgery.
25 Nov 2022
Researchers led by Osaka University identified plasma proteins associated with critical pathogenesis in COVID-19. Using a novel blood proteomics method, the researchers evaluated two discovery cohorts and one validation cohort of patients with COVID-19 and healthy volunteers. Cell adhesion proteins WFDC2, GDF15, CHI3L1, and KRT19 were shown to be associated with disease severity in patients with COVID-19, and may serve as potential targets for therapies to treat COVID-19 infection.
22 Nov 2022
The research team investigated the role of D-amino acids in severe viral infection. Mouse models of influenza A and COVID-19 infection and patients with severe COVID-19 demonstrated reduced D-amino acid levels in the blood. Supplementation with D-alanine mitigated body weight reduction in IAV model mice and improved survival in COVID-19 model mice. D-amino acids may represent potential biomarkers and therapeutic agents for the treatment of severe viral infection.
21 Nov 2022
Intestinal bacteria composition is crucial to driving the recovery of neutrophils counts in the blood of mice following treatments such as stem cell transplants or chemotherapy.
18 Nov 2022
Exploring virtual human-agent relationships, A fly protein gives clue for human cancers, Rare earth elements formed in neutron star mergers 💥, One-stop process for hydrogen production. Read all in the November's Editor's Choice plus Upcoming event K4DM KNOWLEDGE MARKETPLACE – Bangkok 2022: Exchanging Ideas for a Democratic Myanmar.
18 Nov 2022
Disturbed transmission via nicotinic acetylcholine receptors in chick fetuses impairs the hatchlings’ preference for animate objects—similar to what is seen in autism spectrum disorder in humans.
17 Nov 2022
Researchers led by Osaka University have shown that a molecule known as ATAD3A is essential for the movement of genetic material inside cellular substructures called mitochondria. Appropriate distribution of this DNA, organized into “nucleoid” structures, is key for the generation of energy by the “respiratory chain” protein complex. This study opens up opportunities for developing new methods to alter nucleoid movement and affect mitochondrial function, thereby providing potential therapies against mitochondrial diseases.
A cross-section of an LNP-RNA
10 Nov 2022
A novel branched lipid that has a high stability in storage and a high efficiency in the delivery of mRNA to cells has been developed.
10 Nov 2022
Giants in History: Indian scientist and physician Upendranath Brahmachari (19 December 1873–6 February 1946) is best known for creating a drug called Urea Stibamine, used to safely and reliably treat visceral leishmaniasis (or Kala-azar), a severe infection caused by the Leishmania parasite.
Go home safe! Home floor plans used to advise seniors at risk of falls
10 Nov 2022
Injury from falls lowers healthy life expectancy and quality of life, especially for older people. In Japan, patients discharged from acute care hospitals have higher incidences of falls. These falls occur more often indoors in places used frequently in daily life. A group of Osaka Metropolitan University researchers conducted a 6-month follow-up survey, after discharge from an acute care hospital, on falls and near-falls, of orthopedic disease patients with a fall history aged 65 or older. The results suggest that preventive intervention instructing patients using their home floor plans may help prevent falls during the early post-discharge period.
09 Nov 2022
Researchers from Osaka University and Dusseldorf University have found a new theranostic compound that effectively shrinks prostate tumor in mice. Theranostics is a cancer treatment that involves finding cancer cells anywhere in the body and delivering targeted radiation to kill those cells, by drugs that contain radioactive isotopes. It means that this compound could be a promising option for treating hormone-resistant metastases in patients with recurrent cancers. This is stated to be tested in an upcoming clinical trial.
08 Nov 2022
The costliness of drug development and the limitations of studying physiological processes in the lab are two separate scientific issues that may share the same solution. Microphysical systems (MPSs) are in vitro platforms made up of cells in a microenvironment that closely mimics that found in the body, allowing scientists to recreate the conditions of tissues found within the body for both further elucidation of biological conditions and systems and for applications such as testing drugs in a more precise model than animal testing allows. However, the advancements that MPSs could provide have been limited up to this point by an inability to accurately record what is happening at a cellular level. Now, a team of scientists has developed an electrochemical sensing platform that could solve this issue. The results were published in Biosensors and Bioelectronics.
07 Nov 2022
Researchers led by Osaka University show that a molecule called T-cadherin can be secreted in a soluble form. Soluble T-cadherin interacts with pancreatic insulin-producing β cells via the Notch signaling pathway to promote their proliferation and increase the production of insulin. Recombinant T-cadherin stimulated Notch signaling in isolated mouse pancreatic islets, which contain β cells, indicating that T-cadherin may have therapeutic potential for diabetes.
07 Nov 2022
Focusing on the imperative of integrating science, policy and clinical practice to advance global One Health movement especially in the aftermath of COVID-19, the Congress will feature sharing by leading global scientists and policymakers on ways to address complex global health challenges.
01 Nov 2022
Triple-negative breast cancer (TNBC) tumors gain immunosuppression and chemoresistance through interactions between interleukin 34 and myeloid-derived suppressor cells, researchers find.
31 Oct 2022
While both protect from severe disease, inactivated SARS-CoV-2 and spike mRNA vaccines trigger different T-cell responses.
31 Oct 2022
Call To Action urges G20 member countries and partners to mobilize adequate resources to close the TB funding gap and save lives.
Cancer immunity induction system
31 Oct 2022
A research group at Osaka Metropolitan University has developed a drug delivery system that activates a strong cellular immune response to attack cancer cells, using one-tenth of the amount of antigen needed in the group’s previous work. By incorporating positively charged cationic lipids into liposomes and adding negatively charged pH-responsive polysaccharides to the surface, the research group increased the uptake efficiency of liposomes encapsulating cancer antigens by dendritic cells by approximately five times, which increased cytokine production by about 100 times. This increased M1-type macrophages, which activate cancer immunity, and decreased M2-type macrophages, which promote cancer growth.
31 Oct 2022
Researchers from Osaka University used a combination of genetic manipulation and protein structural analysis to determine how the position of “bulky” amino acids influences the ability of efflux pump inhibitors to bind bacterial pump proteins and so reduce their resistance to antibiotics. This work has implications for our understanding of bacterial antibiotic resistance, and may be useful in the rational design of drugs that target bacteria that have evolved antibiotic resistance.
25 Oct 2022
Small neighboring galaxy filled with dark matter detected with gamma rays, How a virus induces heart inflammation, Shedding light on the happy hormone, Microfossils may hold key evolution clues. Read all in the October's Editor's Choice plus Upcoming event KNOWLEDGE MARKETPLACE – Bangkok 2022: Exchanging of ideas for a Democratic Myanmar.
23 Oct 2022
Published in 1693, Hortus Indicus Malabaricus offers a glimpse into the history of medical and natural sciences of South Asia.
17 Oct 2022
Researchers from Osaka University have developed a skin-like device to measure brain activity via electroencephalography, which uses electrodes to measure electrical activity on the scalp (reflecting underlying brain activity). The device has other useful applications, such as measuring heart rate and blood oxygen levels. Wearable devices that can remotely assess brain health in everyday settings are likely to improve healthcare for millions of people worldwide.
17 Oct 2022
Researchers from Osaka University have shown that deficiency of the protein Favine can lead to accelerated development of atherosclerosis. Loss of Favine in a mouse atherosclerosis model also led to calcification and thrombus development in the blood vessels of the mice. Prior to this, no mouse models for calcification or thrombus formation existed, hindering atherosclerosis research. This work also identifies Favine and its downstream signaling pathway, known as MEF2C-KLF2, as potential therapeutic targets for atherosclerosis.
17 Oct 2022
The National Health Innovation Centre, Singapore (NHIC) has launched a Clinical Innovation and Adoption Initiative to nurture promising healthtech projects for adoption and scaling across healthcare clusters in Singapore.
14 Oct 2022
Researchers from Osaka University have found that the Vibrio cholerae colonization factor TcpF forms a flower-shaped trimer to specifically bind to the minor pilus protein TcpB resulting in secretion by the type 4 pilus secretion system into the extracellular space. This finding could help lead to the development of a novel anti-adhesive drug that selectively interrupts the TcpF-TcpB interaction, which may replace antibiotics in the treatment of cholera.
14 Oct 2022
Researchers from Osaka University have developed a computational analysis tool called CAPITAL for comparative analysis of single-cell RNA sequencing data with complicated branching trajectories. As cells undergo a dynamic process, they can be placed on a “pseudotime trajectory” to analyze the gene expression changes throughout the process. While previously only straightforward linear trajectories could be compared, CAPITAL is proven to be able to accurately compare branching trajectories, significantly advancing the field of high-throughput single-cell sequencing.
10 Oct 2022
The SARS-CoV-2 Omicron variant escapes the immune response better than its coronavirus ancestors, but has also facilitated our transition to a society that can live with COVID-19.
06 Oct 2022
Researchers from Osaka University have found that serum albumin interferes with β2m amyloid fibril formation through macromolecular crowding. Monitoring serum albumin concentrations could therefore help prevent patients from developing dialysis-related amyloidosis, a serious complication of long-term dialysis.
Editor's Choice
29 Sep 2022
Linked lanthanides shine light on crystal engineering, New technique reveals hidden genome, Red, white and blue alerts for dangerous bacteria & Windows gain competitive edge over global warming. Read all in the September's Editor's Choice plus this month's Asia Research News 2022 magazine pick - Floating sensors to gather ocean data.

Events

27 Jul 2022
BIO Asia–Taiwan is Asia's largest biotech networking event, and is jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO).
07 Nov 2022
FCS2022 is jointly organized by eight major research institutes in Singapore and includes a line-up of internationally renowned cancer experts. The conference converges the latest cancer discoveries around the world and promises ground-breaking and innovative insights into cancer research.
17 Jan 2022
World’s brightest minds converge at virtual summit to inspire young researchers and discuss key issues
01 Nov 2021
We invite scientists, doctors, students and other delegates engaging in scientific research related to cancer to join us at Singapore’s preferred cancer conference.
12 Oct 2021
The Asia's Largest Partnering “BioJapan” will be held both digitally and physically. Meet your potential business partners in this Partnering Event!
07 Oct 2021
The National Healthcare Group (NHG) is proud to present the 19th Edition of the Singapore Health & Biomedical Congress (SHBC).
24 Feb 2021
INTERPHEX Week Osaka is Asia's leading exhibition for pharmaceutical industry, consists of 2 exhibitions for pharmaceutical technologies - INTERPHEX OSAKA (Manufacturing & Packaging) and PharmaLab Expo OSAKA (Pharma R&D and Drug Discovery).
23 Nov 2020
Global health emergencies look set to be a part of our lives. What awaits us in 2021 and what lessons can we draw from COVID-19 coverage? How can we support newsrooms and journalists for more informed and impactful journalism about global scientific, technical and human challenges? What role does journalism play in seeking solutions for a better world that is both healthy, and sustainable?
27 Nov 2020
ACRLS 2020 aims to contribute to strengthening cooperation and relationship among members worldwide and forming a strong global network by providing various benefits to robotic clinics in rapidly growing nations throughout Asia.
25 Nov 2020
Asia's Leading Pharma & Bio Tech Show will be held as scheduled from November 25-27, 2020 at Makuhari Messe, Japan. It will be held both on-site and online.
16 Nov 2020
Optimising Clinical Trials | Commercialising Great Science | Partnering for Growth
02 Nov 2020
We invite scientists, doctors, students and other delegates engaging in scientific research related to cancer to join us at Singapore’s preferred cancer conference.
01 Oct 2020
The 6th annual RNA Biology Symposium jointly organized by the RNA Biology Centre of CSI Singapore (NUS), Skin Research Institute of Singapore (A*STAR), Duke-NUS Medical School, School of Biological Sciences (NTU) and Singapore-MIT Alliance for Research and Technology (SMART)
The Khwarizmi International Award (KIA) acknowledges the efforts made by researchers, innovators and inventors from across the globe and to appreciate their high quality research work and contributions to different fields of science and technology.
26 Jun 2020
Flattening the Curve with Digital Health: Episode 7 - Australia
18 Jun 2020
Flattening the Curve with Digital Health: Episode 6 - Thailand
10 Jun 2020
Flattening the Curve with Digital Health: Episode 5 - Japan
04 Jun 2020
Flattening the Curve with Digital Health; Episode 4 - Malaysia
23 Sep 2020
Adapting to COVID 19, and driving a pivotal change in drug trials, market penetration, pricing and regulatory compliance
02 Sep 2020
Celebrating and learning from COVID 19 success stories to shape new frontiers in patient experience, healthtech and innovation.
21 May 2020
Flattening the Curve with Digial Health - Episode 2: Singapore
28 May 2020
Flattening the Curve with Digital Health: Episode 3 - South Korea
14 May 2020
Flattening the Curve with Digital Health - Episode 1 - China
14 Oct 2020
Asia's Premier Partnering Event for the Global Biotechnology Industry. This year’s exhibition will be held as originally planned at Pacifico Yokohama. BioJapan partnering is available both physically and virtually. Plus some seminars will be available online.
22 Jul 2020
Due to the COVID-19 pandemic affecting international travel, this year's event will be a unique blend of online and live gatherings — BIO Asia–Taiwan 2020 Online + Live, to be held July 22-26 in Taipei, Taiwan.
03 Nov 2020
Your go-to event to reach out to key decision makers in the pharmaceutical industry. The event will be delivered digitally from 3-5 November 2020.
09 Dec 2019
The ASEAN Emerging Researchers Conference is a flagship programme of the ASEAN Young Scientists Network; the official platform for young researchers in the region.
08 Dec 2020
Asia's pharma & biotech virtual festival - Phar-East is the premier meeting place for senior executives from Asia’s pharma and biotech industry.
26 Feb 2020
Japan's Leading Exhibition for Pharmaceutical R&D and Manufacturing Technologies!

Researchers

Dr Singh is working as an Additional Professor of Radiology. Besides specializing in medical Imaging, he has received certifications in Global Health, Science Diplomacy and Biomedical Research. His areas of interest and expertise are as follows: Radiology, Nuclear Medicine, Medicine, Health, Public Health, Global Health, Health Policy, Health Systems, evidence-based healthcare and Healthcare leadership.
Duke-NUS Medical School
Dr Kwa is currently a Pharmacy Clinician Scientist and Assistant Director, Pharmacy (Research), at the Singapore General Hospital. She specializes in critical care medicine, infectious diseases and antimicrobial resistance research.
Duke-NUS Medical School
 Liu Nan
Dr Liu Nan is an Associate Professor at Centre for Quantitative Medicine and Programme in Health Services and Systems Research, Duke-NUS Medicine School. His research focuses on health services research, emergency and prehospital care, cardiology, medical informatics, and health innovation
Suraj Bhattarai is a global health specialist and tropical medicine physician with research interests in infectious disease epidemiology and surveillance, health systems, and urban health. He is a co-founder and research fellow at the Global Institute for Interdisciplinary Studies, a Kathmandu-based academic institute that promotes and conducts interdisciplinary research. He is a member of Global Young Academy and an Alumni steering committee member of IAP-Young Physician Leaders Programme. He obtained medical training in Nepal and masters in Tropical Medicine & International Health from the LSHTM, UK.
Osaka City University
Takami Tomiyama
Takami Tomiyama is currently an Associate Professor at the Graduate School of Medicine of Osaka City University.
International Islamic University Malaysia (IIUM)
Dr. Salizar Binti Mohamed Ludin is an Assoc. Prof at the Kulliyyah of Nursing of International Islamic University Malaysia.
Universiti Teknologi MARA (UiTM)
Department of Microbiology / Biomolecular Sciences Universiti Teknologi MARA Malaysia
Osaka City University
Dr. Akira Kaneko
Akira Kaneko was appointed as Professor of Parasitology of Osaka City University in 2010. Since then, he has conducted global health research with a particular focus on malaria elimination on islands in Vanuatu, Oceania and Lake Victoria, Kenya.
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Jung Ah Cho
Jung Ah Cho is a Visiting Professor at the School of Undergraduate Studies, College of Transdisciplinary Studies, DGIST.
Osaka City University
Prof. Hiromitsu Toyoda
Hiromitsu Toyoda is an associate professor at the Graduate School of Medicine of Osaka City University.
Osaka City University
Kazuhisa Asai
Kazuhisa Asai is currently an associate professor at the Graduate School of Medicine of Osaka City University.
Osaka City University
Tomoya Kawaguchi is a professor at Osaka City University. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer, EGFR Positive Lung Cancer, and Chronic Obstructive Pulmonary Disease.
The Education University of Hong Kong (EdUHK)
Picture of Dr. Anna Kam Chi-shan
Dr.Anna Kam's research interests include advanced technologies in aural rehabilitation, automated hearing screening, tinnitus management and auditory processing.
The Education University of Hong Kong (EdUHK)
Dr. Yuen has dual professional qualifications as an audiologist and a speech-language pathologist (or speech therapist). He is also an experienced cochlear implant clinical specialist audiologist.
Duke-NUS Medical School
Picture of Ann-Marie Chacko
Prof. Ann Marie Chacko lead the translational efforts for a portfolio of in vivo PET, SPECT, CT and optical imaging agents that span key therapeutic areas including oncology, immunology, infectious disease and neurobiology.
Duke-NUS Medical School
Prof. Patrick Tan's research focuses on developing genomic approaches to unlock the molecular and clinical diversity of gastric cancer (aka stomach cancer)- a leading cause of global cancer mortality.
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Picture of Prof.Sohee Kim
Prof.Sohee Kim's research focuses are the development of 2D and 3D flexible neural interfaces including brain interfaces, peripheral nerve interfaces, retina interfaces; polymer-based microfabrication technologies for soft bio-MEMS (micro-electro-mechanical system); and electrophysiology tools for zebrafish
Duke-NUS Medical School
Picture of Prof. David Bruce Matchar
Prof Matchar's research relates to clinical practice improvement - from the development of clinical policies to their implementation in real world clinical settings
Duke-NUS Medical School
Prof. Ooi Eng Eong
Professor Ooi Eng Eong is a clinician-scientist by training and his research on dengue is positioned at the interface between clinical epidemiology, virology and immunology. His laboratory is interested in how antibodies either protect against or enhance dengue virus infection and what viral factors influence epidemic dengue activity.
Hiroshima University
Yohei Kawano is currently and Associate Professor at the Department of Immunology, Graduate School of Biomedical and Health Sciences, Hiroshima University.
Hiroshima University
Prof. Kiyomi Shitaoka's research aims to obtain effective antibody genes and T cell receptor genes by single-cell analysis of B cell and T cell receptors on lymphocytes. In addition, to apply these genes to develop new treatments for overcoming infectious diseases and cancer.
Hong Kong Baptist University (HKBU)
Picture of Dr. Ren Kangning
Dr. Ken is currently an assistant professor in the department of Chemistry at HKBU. His current research interests center on advanced analytical chemistry technologies, with particular emphasis on creating and applying novel instrumental analysis technologies based on microfluidics and materials engineering.
Hiroshima University
Prof. Tomoharu Yasuda
Prof. Tomoharu Yasuda's laboratory studies how immune system is regulated through the antigen receptor, intracellular signaling and lymphocyte programming.
Duke-NUS Medical School
Picture of Prof. Antonio Bertoletti
Prof. Antonio Bertoletti's current research focuses on the development of new immunological based therapies (TCR-redirected T cells, HLA-peptide specific antibodies) for the treatment of HBV and Hepatocellular carcinoma (HCC), and the characterization of human intra-sinusoidal hepatic immune system.
Duke-NUS Medical School
Picture of Anthony Tanoto Tan
Dr. Anthony Tan is actively involved in clinical trials in Singapore and China to test the safety and efficacy of adoptively transferring T cells engineered against HCC with HBV integration in collaboration with Lion TCR Pte Ltd.
Picture of Goh Bee Tin
Cl A/Prof Goh Bee Tin is Head and Senior Consultant in the Department of Oral and Maxillofacial Surgery (OMS), Research Director and Deputy Director (Research and Education) at the National Dental Centre of Singapore (NDCS)Education. Her research interests include bone tissue engineering and mandibular reconstruction.
Hong Kong Baptist University (HKBU)
Picture of Ken Yung Kin-Lam
Professor Ken's current research mainly focuses on the causes and treatments of neurodegenerative diseases. His lab has developed a nanomaterial-based technology for harvesting autologous neural stem cells from the brain of living subjects.
Dr. Yuichi Ohya
Dr Yuichi Ohya’s research fields are functional polymers and biomaterials, especially biodegradable polymers and drug delivery systems.
Ana Carina Manjua
Ana Carina Manjua's current PhD work is in the design and fabrication of a biological inspired artificial microfluid platform for drug screening.
Dr. Indika Neluwa-Liyanage is a lecturer in Biochemistry at the Faculty of Medical Sciences of University of Sri Jayewardenepura. His research focuses on the metabolic alterations underlying autism spectrum disorders and inherited metabolic disorders.

Giants in history

Maharani Chakravorty (1937 – 2015) was one of India’s earliest molecular biologists whose research paved the way for advances in the treatment of bacterial and viral infections.
Archana Sharma (16 February 1932 - 14 January 2008) conducted research into plant and human genetics that expanded the understanding of both botany and human health. In relation to botany, she uncovered the means by which asexually-reproducing plants evolve into new species.
The first Thai woman to receive a degree in medicine, Margaret Lin Xavier (29 May 1898 – 6 December 1932), is best remembered for her compassion towards her less privileged patients.
In 1915, pathologist Katsusaburo Yamagiwa and his research assistant Koichi Ichikawa became the first to prove that chronic exposure to chemicals can cause cancer.
In 1915, Koichi Ichikawa along with pathologist Katsusaburo Yamagiwa became the first to prove that chronic exposure to chemicals can cause cancer.
Husband and wife team, Kimishige (3 December 1925 – 6 July 2018) and Teruko Ishizaka (28 September 1926 – 4 June 2019) discovered the antibody class Immunoglobulin E (IgE) that triggers allergic reactions. They also discovered that IgE antibodies attach to white blood cells, known as mast cells, releasing histamine, which causes allergic reactions.
Husband and wife team, Kimishige (3 December 1925 – 6 July 2018) and Teruko Ishizaka (28 September 1926 – 4 June 2019) discovered the antibody class Immunoglobulin E (IgE) that triggers allergic reactions. They also discovered that IgE antibodies attach to white blood cells, known as mast cells, releasing histamine, which causes allergic reactions.
Japanese chemist Takamine Jokichi (3 November 1854 – 22 July 1922) founded the Tokyo Artificial Fertilizer Company, where he isolated a starch-digesting enzyme (named takadiastase) from the fungus Aspergillus oryzae.
Ground-breaking cancer researcher Kamal Jayasing Ranadive (8 November 1917 – 11 April 2001) advanced the understanding of the causes of leukaemia, breast cancer and oesophageal cancer through the use of animal models. She was also among the first to recognise how susceptibility to cancer is linked to tumour-causing interactions between hormones and viruses.
The research of Filipino pharmaceutical chemist Luz Oliveros-Belardo (3 November 1906 – 12 December 1999) focussed on essential oils and other chemicals derived from native Philippine plants.
Thai physician and conservationist Boonsong Lekagul (1907 – 1992) made major contributions to the preservation of his country’s wildlife.
Indian scientist and physician Upendranath Brahmachari (19 December 1873–6 February 1946) is best known for creating a drug called Urea Stibamine, used to safely and reliably treat visceral leishmaniasis (or Kala-azar), a severe infection caused by the Leishmania parasite.
Filipino chemist and pharmacist Manuel A. Zamora (29 March 1870 – 9 July 1929) is best remembered for his discovery of the tiki-tiki formula to combat beriberi, a disease caused by Vitamin B1 deficiency.
Korean parasitologist Seung-Yull Cho (16 November 1943 – 27 January 2019) is remembered largely for his pioneering works to control infections caused by helminthic parasites and his contribution to journal publishing.
Fe Villanueva del Mundo (27 November 1911 – 6 August 2011) was a Filipina paediatrician who founded the Philippines’ first paediatric hospital.
After witnessing death and suffering as a youth in his home village during World War II, Nguyễn Tài Thu (6 April 1931 – 14 February 2021) set his sights on alleviating pain by becoming a doctor. After studying Traditional Chinese Medicine in China in the 1950s, Thu returned to Vietnam to serve in military hospitals. Eventually, he became the country’s foremost practitioner of acupuncture, a technique he first learned by inserting needles into himself.
Minoru Shirota (April 23, 1899 – March 10, 1982) was a Japanese microbiologist who invented the popular fermented drink Yakult.
Wu Lien-teh (10 March 1879 – 21 January 1960) was a Malaysian-born doctor who invented a mask that effectively suppressed disease transmission. Winning the prestigious Queen’s Scholarship enabled Wu to become the first Chinese student to study medicine at the University of Cambridge.
David T. Wong (born 1936) is a Hong Kong-born American neuroscientist who is best known for discovering the antidepressant drug fluoxetine, better known as Prozac.
Indian organic chemist Asima Chatterjee (1917 to 2006) studied the medicinal properties of plant products, especially compounds known as vinca alkaloids.
Chika Kuroda (24 March 1884 – 8 November 1968) was a Japanese chemist whose research focussed on the structures of natural pigments.
Umetaro Suzuki (7 April 1874 – 20 September 1943) was a Japanese scientist best remembered for his research on beriberi, a disease caused by vitamin B1 deficiency, characterized by limb stiffness, paralysis and pain.
Salimuzzaman Siddiqui (19 October 1897 – 14 April 1994) was an artist and chemist from Pakistan whose research focused on natural products from plants.
Barry Paw (29 August 1962 – 28 December 2017) was a biologist and oncologist who discovered several novel genes and their functions in red blood cells.
Syed Qasim Mehdi (13 February 1941 – 28 September 2016) was a Pakistani molecular biologist who was a founding member of the Human Genome Diversity Project (HGDP), which assessed human diversity by studying human migration, mutation rates, relationships between different populations, genes involved in height and selective pressure.
Tsai-Fan Yu (1911 – 2 March 2007) was a Chinese-American physician and researcher who was the first female full professor at Mount Sinai School of Medicine. She discovered that gout, a condition characterized by the painful inflammation of joints, was caused by elevated levels of uric acid in the bloodstream.
Min Chueh Chang (10 October 1908 – 5 June 1991) was a Chinese-American biologist who studied fertilization in mammalian reproduction.
A Japanese surgeon, Tetsuzo Akutsu (20 August 1922 – 9 August 2007) built the first artificial heart capable of keeping an animal alive.
Ogino Ginko (3 March 1851 – 23 June 1913) was the first registered female doctor to practise modern medicine in Japan.
Esther Park (1877-1910), born Kim Jeom-dong, was the first female Korean physician to practise modern medicine in Korea and trained the first generation of Korean female doctors.